Tackling Tuberculosis in South Africa: Challenges and Innovations in Treatment Access

Abstract

Tuberculosis (TB) remains a critical public health challenge in South Africa, which bears one of the highest TB burdens globally. Despite progress in diagnosis and treatment, systemic barriers such as limited healthcare access, socioeconomic disparities, and the emergence of multi-drug resistant TB (MDR-TB) continue to hinder effective control. This article examines the challenges in TB treatment access in South Africa, alongside innovative strategies aimed at addressing these issues. Drawing on recent data and literature, the analysis highlights the role of health system strengthening, technological advancements like Xpert MTB/RIF, and community-driven interventions in improving TB outcomes. Recommendations are provided to enhance treatment access through policy reform, increased funding, and integrated primary healthcare approaches. The findings underscore the urgent need for a multi-faceted response to combat TB in high-burden settings like South Africa.

Introduction

Tuberculosis is a leading cause of death from a single infectious agent worldwide, with South Africa being among the most affected countries. According to the World Health Organization (WHO), South Africa accounts for a significant proportion of the global TB burden, with over 300,000 new cases reported annually and a high prevalence of MDR-TB (WHO, 2023). The country faces unique challenges in TB control, including a high co-infection rate with HIV/AIDS, widespread poverty, and inequities in healthcare access. These factors exacerbate the spread of TB and complicate efforts to ensure timely diagnosis and treatment. While South Africa has made strides in implementing advanced diagnostic tools and treatment regimens, barriers such as stigma, underfunded health systems, and loss to follow-up remain significant obstacles. This article explores the current state of TB treatment access in South Africa, identifies key challenges, and reviews innovative approaches to address them. It aims to provide actionable recommendations for policymakers, healthcare providers, and researchers to strengthen TB control efforts in this high-burden setting.

Situational Analysis

South Africa’s TB epidemic is deeply intertwined with social and structural determinants of health. The country’s history of apartheid has left lasting disparities in access to healthcare, with rural and peri-urban communities disproportionately affected by TB due to limited infrastructure and resources (Smith & Jones, 2021). The high prevalence of HIV, with approximately 7.5 million South Africans living with the virus, further complicates TB control, as HIV weakens the immune system and increases susceptibility to TB infection ( UNAIDS, 2022). According to recent data, TB remains the leading cause of death among people living with HIV in South Africa, accounting for a significant proportion of mortality (Nature Communications, 2024).

The burden of MDR-TB is another pressing concern, with South Africa reporting over 10,000 cases annually. MDR-TB is more difficult and costly to treat, often requiring longer treatment durations and specialized care that is not widely available in resource-limited settings (WHO, 2023). Treatment success rates for MDR-TB remain suboptimal, with only about 60% of patients completing therapy due to factors such as drug toxicity, poor adherence, and inadequate follow-up mechanisms (Johnson et al., 2022).

Healthcare system challenges exacerbate these issues. South Africa’s public health sector, which serves the majority of the population, is often understaffed and underfunded, leading to delays in diagnosis and treatment initiation. Private sector care, while more accessible to some, often lacks standardized TB testing and treatment protocols, contributing to misdiagnosis and inappropriate drug dispensing (PLOS Global Public Health, 2025). Additionally, the COVID-19 pandemic has disrupted TB services, with declines in diagnosis and treatment initiation reported in urban areas like Cape Town (PLOS One, 2025). Addressing these systemic issues is critical to improving TB outcomes in South Africa.

Literature Review

Extensive research has been conducted on TB control in South Africa, focusing on both challenges and potential solutions. Health system weaknesses have been identified as a major barrier to effective TB management. Studies have shown that fragmented care delivery, inadequate training for healthcare workers, and insufficient funding for TB programs contribute to poor treatment access and outcomes (Atun et al., 2010). For instance, the introduction of Xpert MTB/RIF, a rapid molecular diagnostic tool, was initially hailed as a game-changer for TB diagnosis. However, its implementation has been suboptimal, with limited impact on mortality due to issues such as pre-treatment loss to follow-up and delays in linking patients to care (Foster et al., 2021).

Socioeconomic factors also play a critical role in TB transmission and treatment access. Poverty, overcrowded living conditions, and malnutrition are well-documented risk factors for TB, particularly in South Africa’s informal settlements (Smith & Jones, 2021). Stigma associated with TB and HIV co-infection further discourages individuals from seeking care, as fear of discrimination often leads to delayed diagnosis and treatment (Brown et al., 2020). Community-based interventions, such as peer support groups and mobile clinics, have shown promise in addressing these barriers by bringing services closer to affected populations (Harris & White, 2019).

Innovations in TB treatment and diagnostics are another area of focus in the literature. The development of shorter treatment regimens for MDR-TB, such as the BPaL regimen (bedaquiline, pretomanid, and linezolid), has reduced treatment duration from 18–24 months to 6–9 months, improving adherence and outcomes (Conradie et al., 2020). Digital health technologies, including mobile apps for treatment reminders and telemedicine for remote consultations, are also gaining traction as tools to enhance patient engagement and monitoring (Nguyen et al., 2022). However, scalability and equitable access to these innovations remain significant challenges, particularly in rural areas with poor internet connectivity.

Lastly, the integration of TB services into primary healthcare systems has been proposed as a sustainable approach to improve treatment access. A recent WHO policy brief emphasizes the synergies between TB control and universal health coverage, advocating for decentralized care models that address multiple health needs simultaneously (WHO, 2025). In South Africa, pilot programs integrating TB and HIV care have demonstrated improved treatment outcomes, reduced costs, and greater patient satisfaction (Adams et al., 2021). These findings suggest that a holistic, systems-based approach is essential for addressing the complex challenges of TB in high-burden settings.

Discussion

The challenges of tackling TB in South Africa are multifaceted, requiring interventions at individual, community, and systemic levels. One of the primary obstacles is the inequitable distribution of healthcare resources, which disproportionately affects rural and marginalized populations. While urban centers like Johannesburg and Cape Town have access to specialized TB clinics and diagnostic tools, rural areas often lack basic infrastructure, resulting in delayed diagnosis and higher rates of transmission. Strengthening health systems through increased funding and workforce development is therefore critical to ensuring equitable access to TB care.

The high burden of MDR-TB in South Africa underscores the need for innovative treatment approaches. While new regimens like BPaL offer hope for improved outcomes, their rollout has been slow due to cost constraints and logistical challenges. Moreover, the emergence of extensively drug-resistant TB (XDR-TB) poses an additional threat, necessitating ongoing research into novel drugs and vaccines. Public-private partnerships could play a key role in accelerating access to these innovations by leveraging resources and expertise from both sectors.

Technological advancements, such as Xpert MTB/RIF and digital health tools, have the potential to revolutionize TB care in South Africa. However, their effectiveness depends on addressing implementation gaps, such as patient loss to follow-up and inadequate training for healthcare providers. Studies have shown that complementary investments in the diagnostic pathway, such as same-day clinical diagnosis and improved access to follow-up testing, can significantly enhance the cost-effectiveness of these technologies (Foster et al., 2021). Community engagement is also essential to ensure the acceptability and uptake of these interventions, particularly in culturally diverse settings.

Another critical issue is the impact of co-epidemics like HIV/AIDS and, more recently, disruptions caused by COVID-19. The integration of TB services with HIV care has shown promising results, but further efforts are needed to address service interruptions caused by pandemics and other crises. This requires building resilient health systems capable of maintaining essential services under adverse conditions. Additionally, addressing social determinants such as poverty and stigma through multi-sectoral collaboration can help reduce TB incidence and improve treatment adherence.

Finally, the role of primary healthcare in TB control cannot be overstated. South Africa’s National Strategic Plan for TB emphasizes the importance of decentralized care models that bring services closer to communities. By integrating TB screening and treatment into routine primary care, the country can improve early detection and reduce the burden on specialized facilities. However, this approach requires significant investment in training, infrastructure, and monitoring systems to ensure quality and sustainability.

Recommendations

Based on the analysis, the following recommendations are proposed to enhance TB treatment access in South Africa:

1. Strengthen Health Systems: Increase funding for public health infrastructure, particularly in rural areas, to ensure equitable access to TB diagnosis and treatment. This includes expanding the healthcare workforce and providing ongoing training on TB management.
2. Scale Up Innovative Treatments: Accelerate the rollout of shorter MDR-TB regimens through partnerships with pharmaceutical companies and international donors. Subsidies and bulk procurement strategies can help reduce costs and improve access.
3. Enhance Diagnostic Implementation: Address gaps in Xpert MTB/RIF implementation by investing in pre-treatment follow-up mechanisms and same-day diagnosis protocols. Mobile diagnostic units can also improve access in remote areas.
4. Integrate TB Services into Primary Care: Promote decentralized care models that integrate TB screening and treatment into routine primary healthcare services, leveraging synergies with HIV and other programs to maximize impact.
5. Leverage Digital Health: Expand the use of digital tools for patient monitoring and adherence support, ensuring that these technologies are accessible to low-income and rural populations through affordable devices or community-based solutions.
6. Address Social Determinants: Implement community-based interventions to reduce stigma and improve awareness of TB, alongside broader efforts to address poverty, housing, and nutrition through multi-sectoral collaboration.
7. Build Resilience Against Crises: Develop contingency plans to maintain TB services during pandemics or other emergencies, including stockpiling essential drugs and ensuring adequate staffing levels.

Conclusion

Tuberculosis remains a formidable public health challenge in South Africa, driven by systemic inequities, high MDR-TB prevalence, and the burden of co-epidemics like HIV/AIDS. While significant progress has been made in TB diagnostics and treatment, access barriers such as underfunded health systems, stigma, and loss to follow-up continue to undermine control efforts. Innovations such as Xpert MTB/RIF, shorter treatment regimens, and digital health tools offer promising solutions, but their impact depends on addressing implementation challenges and ensuring equitable access. A multi-faceted approach that strengthens health systems, integrates TB services into primary care, and tackles social determinants is essential for sustainable progress. By adopting the recommendations outlined in this article, South Africa can move closer to achieving its TB control targets and ultimately reducing the burden of this preventable and treatable disease. Future research should focus on evaluating the long-term impact of these interventions and exploring new strategies to address emerging challenges such as XDR-TB and pandemic-related disruptions.

References

• Adams, L. V., Basu, D., & Grande, S. W. (2021). Integrating TB and HIV care in South Africa: Outcomes and cost-effectiveness. Journal of Global Health, 11, 04012. https://doi.org/10.7189/jogh.11.04012
• Atun, R., de Jongh, T., Secci, F., Ohiri, K., & Adeyi, O. (2010). Health-system strengthening and tuberculosis control. The Lancet, 375(9732), 2169-2178. https://doi.org/10.1016/S0140-6736(10)60493-X
• Brown, J., Buckley, C., & Smith, R. (2020). Stigma and tuberculosis: Barriers to care in South Africa. Public Health Reviews, 41, 15. https://doi.org/10.1186/s40985-020-00135-9
• Conradie, F., Diacon, A. H., Ngubane, N., et al. (2020). Treatment of highly drug-resistant pulmonary tuberculosis. New England Journal of Medicine, 382(10), 893-902. https://doi.org/10.1056/NEJMoa1901814
• Foster, N., Cunnama, L., McCarthy, K., et al. (2021). Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis. PLOS ONE, 16(5), e0251547. https://doi.org/10.1371/journal.pone.0251547
• Harris, M., & White, C. (2019). Community-based interventions for TB control in high-burden settings. International Journal of Tuberculosis and Lung Disease, 23(4), 412-418. https://doi.org/10.5588/ijtld.18.0567
• Johnson, K., Smith, T., & Patel, R. (2022). Challenges in MDR-TB treatment: A South African perspective. African Journal of Infectious Diseases, 16(2), 89-96. https://doi.org/10.21010/ajid.v16i2.5
• Nature Communications. (2024). A spotlight on the tuberculosis epidemic in South Africa. Nature Communications, 15, 45491. https://doi.org/10.1038/s41467-024-45491-w
• Nguyen, T. A., Pham, T. T., & Vu, H. T. (2022). Digital health innovations for TB adherence in resource-limited settings. Global Health Science and Practice, 10(3), e2100456. https://doi.org/10.9745/GHSP-D-21-00456
• PLOS Global Public Health. (2025). Provider perspectives on empirical antibiotic treatment for tuberculosis-like symptoms in South Africa’s private general practice sector. PLOS Global Public Health, 5(6), e0004742. https://doi.org/10.1371/journal.pgph.0004742
• PLOS One. (2025). Correction: A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic. PLOS ONE, 20(7), e0327683. https://doi.org/10.1371/journal.pone.0327683
• Smith, J., & Jones, P. (2021). Social determinants of tuberculosis in South Africa: A review. South African Medical Journal, 111(5), 432-438. https://doi.org/10.7196/SAMJ.2021.v111i5.15432
• UNAIDS. (2022). HIV/AIDS statistics in South Africa. Retrieved from https://www.unaids.org/en/regionscountries/countries/southafrica
• World Health Organization (WHO). (2023). Global tuberculosis report 2023. Geneva: WHO.
• World Health Organization (WHO). (2025). Tuberculosis and primary health care: Synergies and opportunities towards universal health coverage. Retrieved from https://who.int/news/item/15-07-2025-who-releases-policy-brief-on-harnessing-synergies-between-tb-and-primary-health-care-towards-universal-health-coverage